Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 21 (RPL34P21)

Target
RPL34P21
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L34 pseudogene 21 (RPL34P21) is a non-functional genomic sequence with significant similarity to the functional *RPL34* gene, which encodes a component of the cytoplasmic 60S ribosomal subunit[5][10]. As a processed pseudogene, RPL34P21 does not produce a protein, is not known to have a biological function, and is not recognized as a drug or therapeutic target. Pseudogenes like RPL34P21 are common for ribosomal protein genes, and their biological roles, if any, are usually limited and speculative; some studies suggest possible noncoding RNA roles, but there is no evidence of this for RPL34P21 specifically[2].\n\nKey distinction:\nDo not confuse RPL34P21 (a pseudogene, not a protein) with its parent gene *RPL34*, which produces ribosomal protein L34, a structural ribosome component sometimes implicated in cancer and cell proliferation[1][4][7].

Other names
RPL34_10_1189RPL34P21
02

Biological functions

Other (No established biological function for the pseudogene itself. The parent gene *RPL34*, not the pseudogene, encodes a ribosomal protein involved in protein synthesis[1][7].)
03

Disease associations

Other (No direct disease association for RPL34P21. The functional parent gene *RPL34* is implicated in cancer and neuropsychiatric diseases, but pseudogenes like RPL34P21 generally lack direct roles[4][7].)

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 21 (RPL34P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 21 (RPL34P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call